about
Sulforaphane as a potential protective phytochemical against neurodegenerative diseasesIsothiocyanates Are Promising Compounds against Oxidative Stress, Neuroinflammation and Cell Death that May Benefit Neurodegeneration in Parkinson's DiseaseNeuroprotective effects of erucin against 6-hydroxydopamine-induced oxidative damage in a dopaminergic-like neuroblastoma cell line.Neuroprotective effects of cyanidin 3-O-glucopyranoside on amyloid beta (25-35) oligomer-induced toxicity.Sulforaphane as an inducer of glutathione prevents oxidative stress-induced cell death in a dopaminergic-like neuroblastoma cell line.Cyanidin 3-O-glucopyranoside protects and rescues SH-SY5Y cells against amyloid-beta peptide-induced toxicity.Benzofuran-based hybrid compounds for the inhibition of cholinesterase activity, beta amyloid aggregation, and abeta neurotoxicity.Neuroprotective effects of anthocyanins and their in vivo metabolites in SH-SY5Y cells.Multitarget-directed drug design strategy: a novel molecule designed to block epidermal growth factor receptor (EGFR) and to exert proapoptotic effects.Neuroprotective effect of sulforaphane in 6-hydroxydopamine-lesioned mouse model of Parkinson's disease.Antioxidant effectiveness of organically and non-organically grown red oranges in cell culture systems.P-glycoprotein (ABCB1) and Oxidative Stress: Focus on Alzheimer's Disease.TRPM2 in the Brain: Role in Health and DiseaseThe Keap1/Nrf2-ARE Pathway as a Pharmacological Target for ChalconesProtective Effects of 6-(Methylsulfinyl)hexyl Isothiocyanate on Aβ-Induced Cognitive Deficit, Oxidative Stress, Inflammation, and Apoptosis in MiceMultitargeted drugs discovery: balancing anti-amyloid and anticholinesterase capacity in a single chemical entitySulforaphane from Cruciferous Vegetables: Recent Advances to Improve Glioblastoma Treatment
P50
Q21285068-24BD0477-F4AA-4015-BF09-C629B81ABAC3Q28079206-3A4331A0-8DFD-47FD-9476-EE6CACBDF68CQ36321714-756B45ED-24C1-473B-9C65-7F6375B829F1Q39740189-809C0E0B-5BDF-4FCD-AAA9-184A790BF97CQ39795340-60968AF4-31A0-48BA-A346-3EB53AC608A3Q39939029-802A3368-B709-48C3-8E73-D9BDC23CB311Q39991065-3CB83B60-B78B-4242-A2E3-9FD64BB3736FQ40091452-9BDCB25F-3BA0-4EC1-92D7-E0491661B046Q40199390-040BEF46-6952-4A37-92BA-FA73923E8910Q42712361-A0572F3E-0B4C-4BFB-A2CA-E823DC2CDC2AQ46647128-FF44C2F2-9E98-4E5C-930A-6DB189CF7E74Q47873232-40A36041-7F8B-4246-AADF-BA8A40729172Q56363453-5748391D-E2AC-4014-8081-AB777D415E57Q56363770-2664D173-D2C3-449E-B043-D929330B4890Q56364791-57A38882-07FC-49FB-A812-5974D9EA1C30Q56985823-488E81CA-0F60-4327-BA83-CFD5417ACC46Q59807366-097255D8-5F3D-4E6A-AF20-D335730188EE
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Fabiana Morroni
@ast
Fabiana Morroni
@en
Fabiana Morroni
@es
Fabiana Morroni
@nl
type
label
Fabiana Morroni
@ast
Fabiana Morroni
@en
Fabiana Morroni
@es
Fabiana Morroni
@nl
prefLabel
Fabiana Morroni
@ast
Fabiana Morroni
@en
Fabiana Morroni
@es
Fabiana Morroni
@nl
P106
P1153
12789232800
P31
P496
0000-0001-6494-5968